Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma.
Yuanxiang LuDongxiao LiGe LiuErwei XiaoSenmao MuYujin PanFangyuan QinYaping ZhaiShao-Feng DuanDeyu LiGuoyi YanPublished in: OncoTargets and therapy (2021)
The current study suggested that CEACAM5, KRT6A, KRT6B, KRT7, and KRT17 may represent novel prognostic biomarkers as well as novel therapeutic targets for poorly differentiated PDAC.